Increased expression of PRL-1 protein correlates with shortened patient survival in human hepatocellular carcinoma

Clinical and Translational Oncology

Volumn 14, Issue 4, 2012, Pages 287-293

  Lu, Jeng Wei ^a   Chang, Jan Gowth ^b   Yeh, Kun Tu ^c,e   Chen, Rong Ming ^d   Tsai, Jeffrey J P ^a   Su, Wei Wen ^c,e   Hu, Rouh Mei ^a  

^a ASIA UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d NATIONAL UNIVERSITY OF TAINAN   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Human hepatocellular carcinoma; Immunohistochemistry; Phosphatase of regenerating liver; PRL 1; Survival

Indexed keywords

ALCOHOL; PHOSPHATASE OF REGENERATING LIVER 1; PRL 1 PROTEIN; PROTEIN TYROSINE PHOSPHATASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GENDER; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENCE RISK; SMOKING; SURVIVAL RATE; SURVIVAL TIME; TUMOR GROWTH; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; PROTEIN TYROSINE PHOSPHATASES; TREATMENT OUTCOME;

EID: 84860777615     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0797-z     Document Type: Article

References (41)

1. WHO (2003) The World Health Report 2003: shaping the future. World Health Organization, Geneva, pp 1-11
2. Bosch FX, Ribes J, Diaz M et al (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127:S5-S16 (Pubitemid 39423365)
3. Llovet JM, Beaugrand M (2003) Hepatocellular carcinoma: present status and future prospects. J Hepatol 38[Suppl 1]:S136-149
4. Nagao Y, Tanaka K, Kobayashi K et al (2004) A cohort study of chronic liver disease in an HCV hyperendemic area of Japan: a prospective analysis for 12 years. Int J Mol Med 13:257-265
5. Van Rensburg SJ, Cook-Mozaffari P, Van Schalkwyk DJ et al (1985) Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer 51:713-726
6. Beasley RP, Hwang LY, Lin CC et al (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2:1129-1133
7. Bessette DC, Qiu D, Pallen CJ (2008) PRL PTPs: mediators and markers of cancer progression. Cancer Metastasis Rev 27:231-252
8. Matter WF, Estridge T, Zhang C et al (2001) Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. Biochem Biophys Res Commun 283:1061-1068 (Pubitemid 32912875)
9. Dumaual CM, Sandusky GE, Crowell PL et al (2006) Cellular localization of PRL-1 and PRL-2 gene expression in normal adult human tissues. J Histochem Cytochem 54:1401-1412 (Pubitemid 44788825)
10. Al-Aidaroos AQ, Zeng Q, Polato F et al (2010) PRL-3 phosphatase and cancer metastasis. J Cell Biochem 111:1087-1098
11. Kato H, Semba S, Miskad UA et al (2004) High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Clin Cancer Res 10:7318-7328 (Pubitemid 39487721)
12. Liang F, Liang J, Wang WQ et al (2007) PRL3 promotes cell invasion and proliferation by downregulation of Csk leading to Src activation. J Biol Chem 282:5413-5419 (Pubitemid 47093772)
13. Polato F, Codegoni A, Fruscio R et al (2005) PRL-3 phosphatase is implicated in ovarian cancer growth. Clin Cancer Res 11:6835-6839 (Pubitemid 41430477)
14. Zhao WB, Li Y, Liu X et al (2008) Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma. Int J Mol Med 22:187-192
15. Radke I, Gotte M, Kersting C et al (2006) Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. Br J Cancer 95:347-354 (Pubitemid 44187596)
16. Bardelli A, Saha S, Sager JA et al (2003) PRL-3 expression in metastatic cancers. Clin Cancer Res 9:5607-5615 (Pubitemid 37499481)
17. Diamond RH, Cressman DE, Laz TM et al (1994) PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol Cell Biol 14: 3752-3762 (Pubitemid 24160782)
18. Li J, Guo K, Koh VW et al (2005) Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases. Clin Cancer Res 11:2195-2204 (Pubitemid 40490178)
19. Zeng Q, Dong JM, Guo K et al (2003) PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res 63:2716-2722 (Pubitemid 36667138)
20. Liu YQ, Li HX, Lou X et al (2008) Expression of phosphatase of regenerating liver 1 and 3 mRNA in esophageal squamous cell carcinoma. Arch Pathol Lab Med 132:1307-1312
21. Xu XR, Huang J, Xu ZG et al (2001) Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci U S A 98:15089-15094 (Pubitemid 34013974)
22. Chen X, Cheung ST, So S et al (2002) Gene expression patterns in human liver cancers. Mol Biol Cell 13:1929-1939 (Pubitemid 34651483)
23. Su WH, Chao CC, Yeh SH et al (2007) OncoDB. HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci. Nucleic Acids Res 35:D727-731
24. Hirohashi SK, Kojiro M, Puig PL et al (2000) Hepatocellular carcinoma. In: Hamilton SR, Aaltonen LA (eds) Pathology and genetics of tumours of the digestive system. IARC Press, Lyon, pp 159-172
25. Greene FL, Page DL, Fleming ID et al (eds) (2002) Digestive system. In: AJCC Cancer Staging Manual, 6th edn. Springer, New York, pp 131-136
26. Chang YS, Yeh KT, Yang MY et al (2005) Abnormal expression of JUNB gene in hepatocellular carcinoma. Oncol Rep 13:433-438
27. Lu JW, Chang JG, Yeh KT et al (2011) Decreased expression of p39 is associated with a poor prognosis in human hepatocellular carcinoma. Med Oncol 28[Suppl 1]:239-245
28. Lu JW, Chang JG, Yeh KT et al (2011) Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis. Acta Histochem 113:833-838
29. Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170
30. Sun JP, Wang WQ, Yang H et al (2005) Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion. Biochemistry 44:12009-12021 (Pubitemid 41285698)
31. Zeng Q, Si X, Horstmann H et al (2000) Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome. J Biol Chem 275:21444-21452 (Pubitemid 30481847)
32. Diamond RH, Peters C, Jung SP et al (1996) Expression of PRL-1 nuclear PTPase is associated with proliferation in liver but with differentiation in intestine. Am J Physiol 271:G121-129 (Pubitemid 26299734)
33. Wang Q, Holmes DI, Powell SM et al (2002) Analysis of stromal-epithelial interactions in prostate cancer identifies PTPCAAX2 as a potential oncogene. Cancer Lett 175:63-69 (Pubitemid 33153045)
34. Kong W, Swain GP, Li S et al (2000) PRL-1 PTPase expression is developmentally regulated with tissue-specific patterns in epithelial tissues Am J Physiol Gastrointest Liver Physiol 279:G613-621
35. Peng Y, Du K, Ramirez S et al (1999) Mitogenic up-regulation of the PRL-1 protein-tyrosine phosphatase gene by Egr-1. Egr-1 activation is an early event in liver regeneration. J Biol Chem 274:4513-4520
36. Luo Y, Liang F, Zhang ZY (2009) PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways. Biochemistry 48:1838-1846
37. Sun JP, Luo Y, Yu X et al (2007) Phosphatase activity, trimerization, and the C-terminal polybasic region are all required for PRL1-mediated cell growth and migration. J Biol Chem 282:29043-29051 (Pubitemid 47606021)
38. Werner SR, Lee PA, DeCamp MW et al (2003) Enhanced cell cycle progression and down regulation of p21(Cip1/Waf1) by PRL tyrosine phosphatases. Cancer Lett 202:201-211 (Pubitemid 37485893)
39. Min SH, Kim DM, Heo YS et al (2009) New p53 target, phosphatase of regenerating liver 1 (PRL-1) downregulates p53. Oncogene 28:545-554
40. Achiwa H, Lazo JS (2007) PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells. Cancer Res 67:643-650 (Pubitemid 46192203)
41. Guo K, Tang JP, Tan CP et al (2008) Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice. Cancer Biol Ther 7:750-757